Zacks gives SCA ‘sell’ rating — 5 notes

Zacks analysts lowered Surgical Care Affiliates form a “hold” to a “sell” rating, according to Petro Global News.

Advertisement

Here are five notes:

1. Recently, Barclays increased their SCA price objective from $42 to $45.

2. JP Morgan & Chase has a “neutral” rating on SCA shares.

3. On Sept. 19, SCA shares traded down 8.22 percent.

4. SCA has a 50-day moving average of $34.42.

5. The 200-day moving average is $37.02.

More articles on surgery centers:
Dr. Craig Amshel opens surgery center to expand healthcare access to Floridians — 4 key points
Orange Regional Medical Center opens ASC — 4 notes
Yearlong CON battle over Green Mountain Surgical Center continues — 5 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.